KO's and organisation of peptidergic feeding behavior mechanisms

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 2, 2001, Pages 143-158

  Beck, B ^a  

^a INSERM   (France)

Author keywords

Bombesin; Corticotropin releasing hormone; Hypothalamus; Knockout mice; MCH; Melanocortins; Neuropeptide Y deficiency; Obesity; Receptor

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR; LEPTIN; MELANOCORTIN; NEUROPEPTIDE Y;

ARCUATE NUCLEUS; BEHAVIOR; BODY WEIGHT; ENERGY BALANCE; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN;

ANIMALS; FEEDING BEHAVIOR; HUMANS; MICE; MICE, KNOCKOUT; NEUROPEPTIDES;

EID: 0035027629     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00003-3     Document Type: Review

References (200)

1. The spread of the obesity epidemic in the United States,1991-1998
2. The obesity epidemic is a worldwide phenomenon
3. Prevalence, evolution dans le temps et conséquences économiques de l'obésité
4. Hypothalamic control of food intake in rats and cats
5. Hypothalamic lesions and adiposity in the rat
6. The lateral hypothalamic area revisited: ingestive behavior
7. Hypothalamic paraventricular lesions produce overeating and obesity in the rat
8. The dorsomedial hypothalamic nucleus revisited: 1998 update
9. Circadian regulation of feeding in rats: suprachiasmatic versus ventromedial hypothalamic nuclei
10. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat
11. Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin
12. Neuropeptide Y, insuline, leptine et contrôle de la masse grasse
13. Central nervous system control of food intake
14. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
15. Hypothalamic CART is a new anorectic peptide regulated by leptin
16. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone
17. A role for glucagon-like peptide-1 in the central regulation of feeding
18. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake
19. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo
20. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
21. Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance
22. The role of galanin in feeding behavior
23. Physiology and pharmacology of corticotropin-releasing factor
24. Cholecystokinin, neurotensin and corticotropin-releasing factor-3 important anorexic peptides
25. The central melanocortin system and energy homeostasis
26. Role of bombesin-related peptides in the control of food intake
27. Effects of peptides: a cross-listing of peptides and their central actions published in the journal Peptides from 1994 through 1998
28. Novel anti-obesity drugs
29. Antisense strategies come of age
30. Antisense technology-biological utility and practical considerations
31. Neuropeptides and obesity
32. Mouse genetics/genomics: An effective approach for drug target discovery and validation
33. The anatomy of neuropeptide Y-containing neurons in rat brain
34. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat
35. Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status
36. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus
37. Neuropeptide-Y secretion increases in the paraventricular nucleus in association with increased appetite for food
38. +-stimulated neuropeptide-Y release into the paraventricular nucleus and relation to feeding behavior in free-moving rats
39. Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus
40. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors
41. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation
42. Elevated neuropeptide-Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating
43. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats
44. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats
45. feeding receptors: are multiple subtypes involved?
46. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
47. Response of neuropeptide Y-deficient mice to feeding effectors
48. Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats
49. Bilateral neural transections at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y
50. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions
51. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus
52. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues
53. Endocrine function of neuropeptide Y knockout mice
54. Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice
55. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
56. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats
57. Behavioral characterization of neuropeptide Y knockout mice
58. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
59. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade
60. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
61. The neuropeptide Y agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice
62. innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse
63. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice
64. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y
65. Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures
66. Ethanol consumption and resistance are inversely related to neuropeptide Y levels
67. Anxiolytic-like action of neuropeptide-Y-mediation by Y1 receptors in amygdala, and dissociation from food intake effects
68. levels in ethanol-naive, alcohol-preferring, and nonpreferring rats and in Wistar rats after ethanol exposure
69. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes
70. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
71. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor
72. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice
73. Role of the Y5 neuropeptide Y receptor in feeding and obesity
74. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice
75. Role of the Y5 neuropeptide Y receptor in limbic seizures
76. Normal feeding behavior, body weight and leptin response require the neuropeptide YY2 receptor
77. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system
78. Potent neuropeptide YY1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake
79. Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors
80. Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists
81. Analysis of neuropeptide Y-induced feeding-Dissociation of Y1-receptor and Y2-receptor effects on natural meal patterns
82. Stimulation of feeding by galanin-Anatomical localization and behavioral specificity of this peptide's effects in the brain
83. Immunohistochemical mapping of galanin-like neurons in the rat nervous system
84. Evidence for a negative ultrashort loop feedback regulating galanin release from the arcuate nucleus-median eminence functional unit
85. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus
86. Galanin in the hypothalamus of fed and fasted lean and obese Zucker rats
87. Galanin regulates prolactin release and lactotroph proliferation
88. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain
89. Quantitative and macronutrient-related regulation of hypothalamic neuropeptide Y, galanin and neurotensin
90. Effects of dietary preference and galanin administration in the paraventricular or amygdaloid nucleus on diet self-selection
91. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity
92. Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury
93. Corticotropin releasing hormone neurons in the paraventricular nucleus are direct targets for neuropeptide Y neurons in the arcuate nucleus: an anterograde tracing study
94. CART peptides in the central control of feeding and interactions with neuropeptide Y
95. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide-Y
96. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide-Y
97. Urocortin, a mammalian neuropeptide related to urotensin I and to corticotropin-releasing factor
98. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
99. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
100. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
101. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain
102. Characterization of corticotropin-releasing factor receptor subtypes
103. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia
104. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
105. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
106. CRF-deficient mice respond like wild-type mice to hypophagic stimuli
107. CRH-deficient mice have a normal anorectic response to chronic stress
108. Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice
109. Behavioral responses to stress are intact in CRF-deficient mice
110. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
111. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
112. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice
113. Disruption of feeding behavior in CRH receptor I-deficient mice is dependent on glucocorticoids
114. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice
115. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance
116. Stimulation corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants
117. Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects
118. Leptin affects food intake via CRF-receptor-mediated pathways
119. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin
120. Lower weight loss and food intake in protein-deprived, corticotropin releasing hormone-deficient mice correlate with glucocorticoid insufficiency
121. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
122. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
123. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
124. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex
125. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency
126. deficiency and peripheral melanocortins in obesity
127. Disproportionate inhibition of feeding in A(Y) mice by certain stressors: A cautionary note
128. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
129. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
130. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
131. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides
132. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse
133. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
134. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice
135. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur
136. Overexpression of Agrt leads to obesity in transgenic mice
137. The yellow mouse obesity syndrome and mechanisms of Agouti-induced obesity
138. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
139. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
140. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
141. The melanin concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization
142. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
143. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
144. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area
145. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and Agouti gene-related protein systems
146. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y
147. Mice lacking melanin-concentrating hormone are hypophagic and lean
148. Investigation of the feeding effects of melanin concentrating hormone on food intake-action independent of galanin and the melanocortin receptors
149. A role for melanin-concentrating hormone in the central regulation of feeding behaviour
150. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight
151. Independent feeding and metabolic actions of orexins in mice
152. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight
153. Hypothalamic hypocretin/orexin and neuropeptide Y: Divergent interaction with energy depletion and leptin
154. Evidence that NPYY1 receptors are involved in stimulation of feeding by orexins (Hypocretins) in sated rats
155. Orexin-induced food intake involves neuropeptide Y pathway
156. Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system
157. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
158. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor
159. Two distinct receptor subtypes for mammalian bombesin-like peptides
160. cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor
161. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy
162. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells
163. Comparison of gene expression for two distinct bombesin receptors subtypes in postnatal central nervous system
164. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity
165. Generation and characterization of mice lacking gastrin-releasing peptide receptor
166. Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor
167. Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice
168. Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors
169. Glucagon-like peptide-1 and satiety
170. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats
171. The glucagon-like peptides
172. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
173. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action
174. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor(-/-) mice
175. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling
176. Neuroendocrine function and response to stress mice with complete disruption of glucagon-like peptide-1 receptor signaling
177. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance
178. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance
179. How tight are your genes? Transcriptional and posttranscriptional regulation of the leptin receptor, NPY, and POMC genes
180. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene
181. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C-elegans
182. Retinal degeneration but not obesity is observed in null mutants of the tubby-like protein 1 gene
183. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic
184. Behavioural assessment of mice lacking D-1A dopamine receptors
185. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
186. Feeding behavior in dopamine-deficient mice
187. Dopamine is required for hyperphagia in Lep (ob/ob) mice
188. Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline
189. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors
190. Lessons from transgenic and knockout animals about noninsulin-dependent diabetes mellitus
191. Transgenic and knockout rodents: Novel insights into mechanisms of body weight regulation
192. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese
193. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3
194. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean
195. Beta 3-adrenergic receptors on white and brown adipocytes mediate beta 3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake-A study using transgenic and gene knockout mice
196. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice
197. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity
198. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein
199. Improved glucose and lipid metabolism in genetically obese mice lacking aP2